Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026)

Prime Medicine (PRME) reported Asset Utilization Ratio of 0.01 for Q1 2026, up 2.95% on a YoY basis from 0.01 in Q1 2025, and down 0.58% quarter-over-quarter from 0.01 in Q4 2025.

Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Prime Medicine has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.01 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 2.95% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (up 2.95% YoY), and the FY2025 full-year result was 0.01, up 19.17% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.01, down from 0.01 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.02 in Q3 2025, with the low at 0.0 in Q2 2024.
  • Historically, Asset Utilization Ratio has averaged 0.01 across 3 years, with a median of 0.01 in 2025.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio soared 689.54% — and 2026, when it climbed 2.95%.
  • Prime Medicine's Asset Utilization Ratio stood at 0.01 in 2024, then jumped by 34.49% to 0.01 in 2025, then slipped by 0.58% to 0.01 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prime Medicine 572.02 Mn 572.02 Mn - 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00